Found: 168
Select item for more details and to access through your institution.
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50026-4
- By:
- Publication type:
- Article
Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy.
- Published in:
- Surgery Today, 2024, v. 54, n. 7, p. 692, doi. 10.1007/s00595-023-02779-6
- By:
- Publication type:
- Article
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 801, doi. 10.1007/s10147-024-02509-z
- By:
- Publication type:
- Article
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 558, doi. 10.1007/s10120-024-01466-w
- By:
- Publication type:
- Article
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 1, p. 151, doi. 10.1038/s41416-023-02484-8
- By:
- Publication type:
- Article
Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 1, p. 27, doi. 10.1007/s10147-023-02422-x
- By:
- Publication type:
- Article
Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7338, doi. 10.1245/s10434-023-13781-0
- By:
- Publication type:
- Article
ASO Visual Abstract: Prognostic Impact of Tumor Markers (CEA and CA19-9) in Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biological Markers for Preoperative Treatment.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A SingleInstitution Retrospective Study.
- Published in:
- Journal of Gastric Cancer, 2023, v. 23, n. 4, p. 609, doi. 10.5230/jgc.2023.23.e41
- By:
- Publication type:
- Article
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 1021, doi. 10.1007/s10555-023-10121-2
- By:
- Publication type:
- Article
Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1191, doi. 10.1007/s10147-023-02370-6
- By:
- Publication type:
- Article
Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched Analysis
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 8, p. 4716, doi. 10.1245/s10434-023-13458-8
- By:
- Publication type:
- Article
ASO Visual Abstract: Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncological Outcomes—A Propensity Score-Matched Analysis
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11067-y
- By:
- Publication type:
- Article
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 4, p. 493, doi. 10.1007/s10120-023-01378-1
- By:
- Publication type:
- Article
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 654, doi. 10.1007/s10147-023-02318-w
- By:
- Publication type:
- Article
Comprehensive data of 4502 patients newly diagnosed with colorectal liver metastasis between 2015 and 2017, and prognostic data of 2427 patients newly diagnosed with colorectal liver metastasis in 2013 and 2014: Third report of a nationwide survey in Japan
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 5, p. 570, doi. 10.1002/jhbp.1252
- By:
- Publication type:
- Article
Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era ‐ a nationwide survey in Japan.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 5, p. 591, doi. 10.1002/jhbp.1256
- By:
- Publication type:
- Article
Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 7932, doi. 10.1002/cam4.5569
- By:
- Publication type:
- Article
Current Strategy to Treat Immunogenic Gastrointestinal Cancers: Perspectives for a New Era.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1049, doi. 10.3390/cells12071049
- By:
- Publication type:
- Article
Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.
- Published in:
- Journal of Gastric Cancer, 2023, v. 23, n. 2, p. 289, doi. 10.5230/jgc.2023.23.e15
- By:
- Publication type:
- Article
Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1473, doi. 10.3390/cancers15051473
- By:
- Publication type:
- Article
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 100, doi. 10.1016/j.clcc.2022.11.002
- By:
- Publication type:
- Article
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
- By:
- Publication type:
- Article
KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1273, doi. 10.1007/s00432-022-03966-7
- By:
- Publication type:
- Article
Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.946850
- By:
- Publication type:
- Article
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221138377
- By:
- Publication type:
- Article
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 121, doi. 10.1007/s10147-022-02263-0
- By:
- Publication type:
- Article
Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 139, doi. 10.1007/s10147-022-02264-z
- By:
- Publication type:
- Article
Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8385, doi. 10.1245/s10434-022-12301-w
- By:
- Publication type:
- Article
ASO Author Reflections: The Role of CEA Optimizing Perioperative Treatments for Colorectal Cancer with Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8394, doi. 10.1245/s10434-022-12372-9
- By:
- Publication type:
- Article
ASO Visual Abstract: Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Clinicopathological characteristics of advanced gastric cancer after Helicobacter pylori eradication.
- Published in:
- JGH Open, 2022, v. 6, n. 12, p. 833, doi. 10.1002/jgh3.12827
- By:
- Publication type:
- Article
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2814, doi. 10.1111/cas.15462
- By:
- Publication type:
- Article
Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer.
- Published in:
- Health Science Reports, 2022, v. 5, n. 4, p. 1, doi. 10.1002/hsr2.673
- By:
- Publication type:
- Article
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13801-1
- By:
- Publication type:
- Article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.
- Published in:
- Langenbeck's Archives of Surgery, 2022, v. 407, n. 4, p. 1345, doi. 10.1007/s00423-022-02434-7
- By:
- Publication type:
- Article
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. e506, doi. 10.1093/oncolo/oyab069
- By:
- Publication type:
- Article
The dawn of precision medicine in diffuse-type gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221083049
- By:
- Publication type:
- Article
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 245, doi. 10.1007/s10120-021-01244-y
- By:
- Publication type:
- Article
Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 24, p. 8820, doi. 10.1002/cam4.4384
- By:
- Publication type:
- Article
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7673, doi. 10.1002/cam4.4303
- By:
- Publication type:
- Article
The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 6, p. 1169, doi. 10.1007/s10120-021-01235-z
- By:
- Publication type:
- Article
A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 6, p. 1320, doi. 10.1007/s10120-021-01199-0
- By:
- Publication type:
- Article
Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab.
- Published in:
- Oncology Letters, 2021, v. 22, n. 5, p. N.PAG, doi. 10.3892/ol.2021.13044
- By:
- Publication type:
- Article
Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting.
- Published in:
- Dose-Response, 2021, v. 19, n. 4, p. 1, doi. 10.1177/15593258211047658
- By:
- Publication type:
- Article
Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94584-9
- By:
- Publication type:
- Article
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 780, doi. 10.1007/s10120-021-01196-3
- By:
- Publication type:
- Article